Skip to main content
📢 -40% on Recombinant Antibody Production. Available until November 16th on your first order. Code: RECAB40

Integrated Therapeutic Antibody Services

Unlock Rapid Antibody Discovery with Proven Experts

  • Fully human antibodies in 4 weeks
  • 3 antibodies on the market
  • From target to clinic
  • Full rights to antibodies

Contact us Talk to our experts

Looking to develop a new therapeutic antibody? Maximize your chances of identifying the best possible candidate to reach clinical phases thanks to ProteoGenix therapeutic antibody discovery services! By partnering with ProteoGenix, you gain access to comprehensive, turnkey solutions—from target production to bioproduction. Whether it’s generating human antibodies against complex targets (including membrane proteins in their native conformation), designing and producing antibody-drug conjugates, or developing stable cell lines capable of yielding titers of several grams per liter, we meet these challenges every day for biotech and biopharma clients of all sizes.

End-to-end therapeutic antibody discovery solutions

Therapeutic antibody discovery services - ProteoGenix

At ProteoGenix, we understand that bringing a therapeutic antibody discovery project to clinical phases requires meticulous attention to detail. That’s why we’ve designed comprehensive and customizable end-to-end solutions combining artificial intelligence with wet lab expertise to ensure your antibody perfectly aligns with your vision.

Our services cover every critical stage, from antigen production to the manufacturing of your lead candidate:

At ProteoGenix, we combine an unmatched range of services with deep technical expertise to deliver fast, reliable, and tailored strategies for advancing your project to clinical stages. At every step, we provide in-depth characterizations to guide your decision-making and maximize your project’s success potential.

Discover the first Human Cancer Phage Display Library

  • Huge diversity: 3.81×1010 (scFv) 3.72×1010(Fab)
  • 48 human donors with 7 different cancers: prostate, colorectal, renal,
    lung, skin, melanoma, acute myeloid leukemia
  • Ideal for Human Cancer Therapeutic Antibody Development

Discover Now

Our Promise #1: Discover human antibodies against any target and pathology

With over 20 years of experience in antibody discovery and development, ProteoGenix has consistently pioneered innovative solutions for the design and production of complex targets, as well as for the discovery of human antibodies against them.

Get the best start with a well-designed antigen

Designing and producing your target are two of the most crucial steps in determining the success of your therapeutic antibody. This process requires antigen design in its native conformation. As experts in gene, peptide, and protein synthesis and expression, we are equipped to produce any type of antigen, including:

  • Haptens
  • Peptides
  • Soluble proteins
  • Membrane proteins in their native conformation
  • Cells
  • DNA

Discover fully human antibodies against any type of antigen

The journey to developing a therapeutic antibody begins with generating a high affinity and high specificity fully human antibody. To help you identify your best lead candidates, our scientists have developed three fully human antibody discovery platforms, both in vitro and in vivo (using a humanized mouse platform), that can adapt to any type of antigen —even non-immunogenic and toxic ones.

Phage Display with Human Antibody Libraries:
  • Choose from one naïve and three diverse immune libraries, depending on your target pathology (cancer, autoimmune disease, COVID-19) to maximize your success
  • Save months of development time by generating fully human antibodies
  • Use the antigen of your choice with phage display technology
  • Fab or scFv format
  • Royalty-free
  • 3 binders guaranteed
  • Antibodies in as little as 4 weeks
Single B Cell Screening on Humanized Mice:
  • Opt for an in vivo technology to obtain highly specific antibodies against your target antigen
  • Save months of development time with fully human antibodies
  • Royalty-free
  • 960 positive clones screened
  • Antibodies in 7 weeks
Hybridoma Generation on Humanized Mice:
  • Choose an in vivo technology that delivers highly specific antibodies against your antigen
  • Save months of development with fully human antibodies
  • Royalty-free

In addition to these three human antibody generation platforms, ProteoGenix also offers advanced nanobody discovery solutions.

Our Promise #2: Create antibodies that match your vision thanks to our antibody engineering platform!

ProteoGenix boasts the most comprehensive antibody engineering platform on the market specifically developped for biotech and biopharmaceutical companies. Whether you’re looking to increase antibody affinity, humanize it, or reformat it into CAR-T, bispecific antibodies, or antibody-drug conjugates, we offer a full suite of compehensive antibody engineering services. Furthermore, by combining these services with our AI-powered platforms, we help you accelerate your antibody development.

Our Promise #3: Take your best candidates to GMP production

The process of developing a therapeutic antibody requires production at various scales—whether for candidate selection, preclinical in vivo and in vitro testing, or clinical lot production. ProteoGenix supports you every step of the way with our three antibody production platforms:

ProteoGenix boasts the most comprehensive antibody engineering platform on the market specifically developped for biotech and biopharmaceutical companies. Whether you’re looking to increase antibody affinity, humanize it, or reformat it into CAR-T, bispecific antibodies, or antibody-drug conjugates, we offer a full suite of compehensive antibody engineering services. Furthermore, by combining these services with our AI-powered platforms, we help you accelerate your antibody development.

High-throughput antibody production

For dozens or even hundreds of different antibodies in parallel

Recombinant antibody production

Using our proprietary XtenCHOTM platform, ideal for preclinical batches

Stable cell line development

Ready for clinical entry (GMP transition possible with our CDMO partners)

Our Promise #4: Make informed decisions with our antibody characterization platform

Taking your therapeutic antibody to clinical phases requires critical decision-making at key stages. To ensure you make the right choices, you need a world-class antibody characterization platform and guidance from therapeutic antibody development experts. Our platform provides detailed insights into the structural and functional properties of your biomolecules, including:

  • Sequence
  • Molecular weight
  • Post-translational modifications
  • Affinity to target (Kd)
  • Stability, and more…

Find more detailed information on our antibody characterization platform on our dedicated page.

Why Choose ProteoGenix for Your Therapeutic Antibody Development?

Expertise in native conformation antigen production

Maximize your chances of ensuring your antibody recognizes its target in vivo.

3 human antibody discovery platforms

Empowering you with the best opportunities to discover antibodies that meet your specific needs.

A unique AI and wet lab combination

This powerful blend allows us to enhance your antibody’s properties and make the right decisions in record time.

Zero risk for you

Our therapeutic antibody discovery process comes with multiple guarantees, allowing you to move forward confidently and risk-free towards bioproduction.

Royalty and IP-free antibodies

At ProteoGenix, we’ve designed a process that’s 100% IP free, so you have full control over your antibody.

A end-to-end solution from antigen design to bioproduction

Trust a single partner to guide you seamlessly from the earliest stages of discovery through to preclinical development.

Contact us Talk to our experts

What does our therapeutic antibody discovery services include?

Core services

Our therapeutic antibody discovery service includes a tailored strategy based on your specifications, antigen design and production, and antibody generation, production, and purification, all according to the chosen method.

Additional services

As experts in therapeutic antibody development, ProteoGenix offers an array of additional services to bring your antibody through to early clinical phases. These can include:

  • Lead candidate engineering: Conjugation to create an antibody-drug conjugate, development of a bispecific antibody or CAR-T, or enhancement of compound properties such as affinity maturation, humanization, and developability.
  • Antibody production: Options include high-throughput production for screening multiple sequences, transient production for early preclinical testing, or stable cell line production for large-scale manufacturing.

The optimal strategy, with or without these additional services, will be developed in collaboration with one of our therapeutic antibody development experts. Have a project or questions? Feel free to contact us by clicking here.

FAQ on our Therapeutic Antibody Discovery Services

Want to discuss your project?

Business people shaking hands in the office. Group of business persons in business meeting. Two entrepreneurs on meeting in board room. Corporate business team on meeting in modern office. Female manager discussing new project with her colleagues. Company owner on a meeting with her employee in her office.

Need a quote or more information? Contact us!

    Cart (0 Items)

    Your cart is currently empty.

    View Products